25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Cassava Sciences Inc
Buy, Hold or Sell?

Let's analyze Cassava Sciences Inc together

I guess you are interested in Cassava Sciences Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Cassava Sciences Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Cassava Sciences Inc

I send you an email if I find something interesting about Cassava Sciences Inc.

1. Quick Overview

1.1. Quick analysis of Cassava Sciences Inc (30 sec.)










1.2. What can you expect buying and holding a share of Cassava Sciences Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$3.94
Expected worth in 1 year
$4.14
How sure are you?
20.0%

+ What do you gain per year?

Total Gains per Share
$0.20
Return On Investment
0.7%

For what price can you sell your share?

Current Price per Share
$29.78
Expected price per share
$20.92 - $42.20
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Cassava Sciences Inc (5 min.)




Live pricePrice per Share (EOD)
$29.78
Intrinsic Value Per Share
$-25.48 - $-10.88
Total Value Per Share
$-21.54 - $-6.94

2.2. Growth of Cassava Sciences Inc (5 min.)




Is Cassava Sciences Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$188.9m$202.4m-$62.3m-44.5%

How much money is Cassava Sciences Inc making?

Current yearPrevious yearGrowGrow %
Making money-$3.8m-$21.1m$17.2m449.8%
Net Profit Margin-222.7%240,708.3%--

How much money comes from the company's main activities?

2.3. Financial Health of Cassava Sciences Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#269 / 957

Most Revenue
#545 / 957

Most Profit
#387 / 957

Most Efficient
#550 / 957
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Cassava Sciences Inc?

Welcome investor! Cassava Sciences Inc's management wants to use your money to grow the business. In return you get a share of Cassava Sciences Inc.

First you should know what it really means to hold a share of Cassava Sciences Inc. And how you can make/lose money.

Speculation

The Price per Share of Cassava Sciences Inc is $29.78. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Cassava Sciences Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Cassava Sciences Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $3.94. Based on the TTM, the Book Value Change Per Share is $0.05 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.20 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Cassava Sciences Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.130.4%-0.08-0.3%-0.47-1.6%-0.19-0.6%-0.12-0.4%
Usd Book Value Change Per Share2.307.7%0.050.2%-0.20-0.7%0.180.6%0.080.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share2.307.7%0.050.2%-0.20-0.7%0.180.6%0.080.3%
Usd Price Per Share12.35-17.95-30.00-26.26-14.27-
Price to Earnings Ratio24.07-3.27--16.59--41.44--26.30-
Price-to-Total Gains Ratio5.37--26.33--37.45--232.35--127.39-
Price to Book Ratio3.14-7.13-7.14-8.39-7.70-
Price-to-Total Gains Ratio5.37--26.33--37.45--232.35--127.39-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share29.78
Number of shares33
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.050.18
Usd Total Gains Per Share0.050.18
Gains per Quarter (33 shares)1.655.89
Gains per Year (33 shares)6.6223.54
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
107-302414
2013404738
30201107162
40261809486
5033250118110
6040320141134
7046390165158
8053460188182
9060530212206
10066600235230

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.02.00.050.0%2.010.00.016.7%2.018.00.010.0%2.038.00.05.0%13.085.00.013.3%
Book Value Change Per Share1.03.00.025.0%2.010.00.016.7%6.014.00.030.0%8.032.00.020.0%38.059.01.038.8%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%2.00.096.02.0%
Total Gains per Share1.03.00.025.0%2.010.00.016.7%6.014.00.030.0%8.032.00.020.0%40.057.01.040.8%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Cassava Sciences Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--2.3010.050+4489%-0.203+109%0.178+1190%0.076+2938%
Book Value Per Share--3.9392.919+35%4.219-7%3.240+22%1.855+112%
Current Ratio--4.0695.891-31%18.935-79%26.643-85%23.012-82%
Debt To Asset Ratio--0.2240.228-2%0.057+294%0.080+181%0.073+209%
Debt To Equity Ratio--0.2890.371-22%0.061+373%0.110+162%0.091+219%
Dividend Per Share----0%-0%-0%-0%
Eps--0.128-0.080+162%-0.469+466%-0.191+249%-0.124+197%
Free Cash Flow Per Share---0.381-0.450+18%-0.402+6%-0.270-29%-0.156-59%
Free Cash Flow To Equity Per Share--1.7330.202+756%-0.150+109%-0.004+100%-0.010+101%
Gross Profit Margin--0.1060.775-86%1.000-89%0.999-89%0.999-89%
Intrinsic Value_10Y_max---10.882--------
Intrinsic Value_10Y_min---25.480--------
Intrinsic Value_1Y_max---0.692--------
Intrinsic Value_1Y_min---1.858--------
Intrinsic Value_3Y_max---2.383--------
Intrinsic Value_3Y_min---6.219--------
Intrinsic Value_5Y_max---4.441--------
Intrinsic Value_5Y_min---11.241--------
Market Cap1428731236.000+59%592506070.000861052849.500-31%1439286000.000-59%1259711083.400-53%684728320.450-13%
Net Profit Margin----2.2270%2407.083-100%3688.875-100%1844.438-100%
Operating Margin----2.4260%2961.944-100%3906.634-100%1953.317-100%
Operating Ratio---2.426-100%-2961.9440%-3906.6090%-1953.3050%
Pb Ratio7.560+59%3.1357.131-56%7.139-56%8.394-63%7.697-59%
Pe Ratio58.031+59%24.0663.274+635%-16.587+169%-41.439+272%-26.301+209%
Price Per Share29.780+59%12.35017.948-31%30.000-59%26.257-53%14.272-13%
Price To Free Cash Flow Ratio-19.550-141%-8.108-10.106+25%-18.748+131%-50.221+519%-33.414+312%
Price To Total Gains Ratio12.944+59%5.368-26.325+590%-37.454+798%-232.355+4428%-127.395+2473%
Quick Ratio--3.8235.574-31%18.112-79%26.035-85%22.845-83%
Return On Assets--0.025-0.025+199%-0.100+495%-0.052+307%-0.093+469%
Return On Equity--0.0330.008+287%-0.106+427%-0.048+248%-0.097+398%
Total Gains Per Share--2.3010.050+4489%-0.203+109%0.178+1190%0.076+2938%
Usd Book Value--188974000.000140038500.000+35%202404000.000-7%155455700.000+22%89007300.000+112%
Usd Book Value Change Per Share--2.3010.050+4489%-0.203+109%0.178+1190%0.076+2938%
Usd Book Value Per Share--3.9392.919+35%4.219-7%3.240+22%1.855+112%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.128-0.080+162%-0.469+466%-0.191+249%-0.124+197%
Usd Free Cash Flow---18270000.000-21576500.000+18%-19305250.000+6%-12975950.000-29%-7481526.900-59%
Usd Free Cash Flow Per Share---0.381-0.450+18%-0.402+6%-0.270-29%-0.156-59%
Usd Free Cash Flow To Equity Per Share--1.7330.202+756%-0.150+109%-0.004+100%-0.010+101%
Usd Market Cap1428731236.000+59%592506070.000861052849.500-31%1439286000.000-59%1259711083.400-53%684728320.450-13%
Usd Price Per Share29.780+59%12.35017.948-31%30.000-59%26.257-53%14.272-13%
Usd Profit--6155000.000-3843000.000+162%-21128750.000+443%-8823850.000+243%-5801175.000+194%
Usd Revenue---587000.000-100%-450.0000%117305.200-100%58652.600-100%
Usd Total Gains Per Share--2.3010.050+4489%-0.203+109%0.178+1190%0.076+2938%
 EOD+5 -3MRQTTM+23 -9YOY+17 -155Y+17 -1610Y+17 -16

3.3 Fundamental Score

Let's check the fundamental score of Cassava Sciences Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1558.031
Price to Book Ratio (EOD)Between0-17.560
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than13.823
Current Ratio (MRQ)Greater than14.069
Debt to Asset Ratio (MRQ)Less than10.224
Debt to Equity Ratio (MRQ)Less than10.289
Return on Equity (MRQ)Greater than0.150.033
Return on Assets (MRQ)Greater than0.050.025
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Cassava Sciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5056.982
Ma 20Greater thanMa 5028.760
Ma 50Greater thanMa 10024.172
Ma 100Greater thanMa 20021.690
OpenGreater thanClose30.720
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About Cassava Sciences Inc

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2 clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was incorporated in 1998 and is based in Austin, Texas.

Fundamental data was last updated by Penke on 2024-09-13 07:39:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Cassava Sciences Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Cassava Sciences Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Cassava Sciences Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-222.7%+222.7%
TTM-222.7%YOY240,708.3%-240,931.1%
TTM-222.7%5Y368,887.5%-369,110.2%
5Y368,887.5%10Y184,443.8%+184,443.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--131.4%+131.4%
TTM-222.7%-212.1%-10.6%
YOY240,708.3%-219.3%+240,927.6%
5Y368,887.5%-370.1%+369,257.6%
10Y184,443.8%-487.5%+184,931.3%
4.3.1.2. Return on Assets

Shows how efficient Cassava Sciences Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Cassava Sciences Inc to the Biotechnology industry mean.
  • 2.5% Return on Assets means that Cassava Sciences Inc generated $0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Cassava Sciences Inc:

  • The MRQ is 2.5%. Using its assets, the company is less efficient in making profit.
  • The TTM is -2.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ2.5%TTM-2.5%+5.0%
TTM-2.5%YOY-10.0%+7.5%
TTM-2.5%5Y-5.2%+2.7%
5Y-5.2%10Y-9.3%+4.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.5%-11.0%+13.5%
TTM-2.5%-11.8%+9.3%
YOY-10.0%-11.2%+1.2%
5Y-5.2%-12.8%+7.6%
10Y-9.3%-14.4%+5.1%
4.3.1.3. Return on Equity

Shows how efficient Cassava Sciences Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Cassava Sciences Inc to the Biotechnology industry mean.
  • 3.3% Return on Equity means Cassava Sciences Inc generated $0.03 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Cassava Sciences Inc:

  • The MRQ is 3.3%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 0.8%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ3.3%TTM0.8%+2.4%
TTM0.8%YOY-10.6%+11.5%
TTM0.8%5Y-4.8%+5.6%
5Y-4.8%10Y-9.7%+4.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.3%-13.8%+17.1%
TTM0.8%-16.1%+16.9%
YOY-10.6%-13.7%+3.1%
5Y-4.8%-18.9%+14.1%
10Y-9.7%-19.1%+9.4%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Cassava Sciences Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Cassava Sciences Inc is operating .

  • Measures how much profit Cassava Sciences Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Cassava Sciences Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Cassava Sciences Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-242.6%+242.6%
TTM-242.6%YOY296,194.4%-296,437.1%
TTM-242.6%5Y390,663.4%-390,906.1%
5Y390,663.4%10Y195,331.7%+195,331.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--286.0%+286.0%
TTM-242.6%-305.1%+62.5%
YOY296,194.4%-241.7%+296,436.1%
5Y390,663.4%-386.0%+391,049.4%
10Y195,331.7%-495.6%+195,827.3%
4.3.2.2. Operating Ratio

Measures how efficient Cassava Sciences Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Cassava Sciences Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM2.426-2.426
TTM2.426YOY-2,961.944+2,964.371
TTM2.4265Y-3,906.609+3,909.036
5Y-3,906.60910Y-1,953.305-1,953.305
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.760-2.760
TTM2.4263.284-0.858
YOY-2,961.9443.432-2,965.376
5Y-3,906.6094.971-3,911.580
10Y-1,953.3056.542-1,959.847
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Cassava Sciences Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Cassava Sciences Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 4.07 means the company has $4.07 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Cassava Sciences Inc:

  • The MRQ is 4.069. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.891. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.069TTM5.891-1.822
TTM5.891YOY18.935-13.044
TTM5.8915Y26.643-20.752
5Y26.64310Y23.012+3.631
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.0693.740+0.329
TTM5.8913.919+1.972
YOY18.9354.741+14.194
5Y26.6435.982+20.661
10Y23.0126.336+16.676
4.4.3.2. Quick Ratio

Measures if Cassava Sciences Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Cassava Sciences Inc to the Biotechnology industry mean.
  • A Quick Ratio of 3.82 means the company can pay off $3.82 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Cassava Sciences Inc:

  • The MRQ is 3.823. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 5.574. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.823TTM5.574-1.751
TTM5.574YOY18.112-12.538
TTM5.5745Y26.035-20.461
5Y26.03510Y22.845+3.189
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.8233.138+0.685
TTM5.5743.448+2.126
YOY18.1124.734+13.378
5Y26.0355.870+20.165
10Y22.8456.481+16.364
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Cassava Sciences Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Cassava Sciences Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Cassava Sciences Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.22 means that Cassava Sciences Inc assets are financed with 22.4% credit (debt) and the remaining percentage (100% - 22.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Cassava Sciences Inc:

  • The MRQ is 0.224. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.228. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.224TTM0.228-0.004
TTM0.228YOY0.057+0.172
TTM0.2285Y0.080+0.149
5Y0.08010Y0.073+0.007
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2240.342-0.118
TTM0.2280.345-0.117
YOY0.0570.306-0.249
5Y0.0800.365-0.285
10Y0.0730.380-0.307
4.5.4.2. Debt to Equity Ratio

Measures if Cassava Sciences Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Cassava Sciences Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 28.9% means that company has $0.29 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Cassava Sciences Inc:

  • The MRQ is 0.289. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.371. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.289TTM0.371-0.083
TTM0.371YOY0.061+0.310
TTM0.3715Y0.110+0.261
5Y0.11010Y0.091+0.020
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2890.394-0.105
TTM0.3710.450-0.079
YOY0.0610.372-0.311
5Y0.1100.447-0.337
10Y0.0910.488-0.397
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Cassava Sciences Inc generates.

  • Above 15 is considered overpriced but always compare Cassava Sciences Inc to the Biotechnology industry mean.
  • A PE ratio of 24.07 means the investor is paying $24.07 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Cassava Sciences Inc:

  • The EOD is 58.031. Based on the earnings, the company is expensive. -2
  • The MRQ is 24.066. Based on the earnings, the company is fair priced.
  • The TTM is 3.274. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD58.031MRQ24.066+33.965
MRQ24.066TTM3.274+20.792
TTM3.274YOY-16.587+19.861
TTM3.2745Y-41.439+44.714
5Y-41.43910Y-26.301-15.139
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD58.031-2.318+60.349
MRQ24.066-2.392+26.458
TTM3.274-2.971+6.245
YOY-16.587-3.470-13.117
5Y-41.439-6.025-35.414
10Y-26.301-6.219-20.082
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Cassava Sciences Inc:

  • The EOD is -19.550. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -8.108. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -10.106. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-19.550MRQ-8.108-11.443
MRQ-8.108TTM-10.106+1.998
TTM-10.106YOY-18.748+8.642
TTM-10.1065Y-50.221+40.115
5Y-50.22110Y-33.414-16.806
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-19.550-3.100-16.450
MRQ-8.108-3.198-4.910
TTM-10.106-3.575-6.531
YOY-18.748-4.670-14.078
5Y-50.221-8.056-42.165
10Y-33.414-8.614-24.800
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Cassava Sciences Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 3.14 means the investor is paying $3.14 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Cassava Sciences Inc:

  • The EOD is 7.560. Based on the equity, the company is overpriced. -1
  • The MRQ is 3.135. Based on the equity, the company is fair priced.
  • The TTM is 7.131. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD7.560MRQ3.135+4.425
MRQ3.135TTM7.131-3.995
TTM7.131YOY7.139-0.008
TTM7.1315Y8.394-1.263
5Y8.39410Y7.697+0.697
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD7.5601.808+5.752
MRQ3.1351.903+1.232
TTM7.1312.210+4.921
YOY7.1392.407+4.732
5Y8.3943.549+4.845
10Y7.6974.082+3.615
4.6.2. Total Gains per Share

2.4. Latest News of Cassava Sciences Inc

Does Cassava Sciences Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Cassava Sciences Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2024-09-03
14:31
Cassava Sciences to Present at the H.C. Wainwright Global Investment ConferenceRead

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Cassava Sciences Inc.

4.8.1. Institutions holding Cassava Sciences Inc

Institutions are holding 28.365% of the shares of Cassava Sciences Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-06-30BlackRock Inc6.71090.000932196491741855.7195
2024-06-30Vanguard Group Inc5.59260.0006268312632664613.8616
2024-06-30State Street Corp2.45330.00061176977834997.6361
2024-06-30Geode Capital Management, LLC2.01620.0011967304654647.2589
2024-06-30Susquehanna International Group, LLP1.44010.00166909246752364304.156
2024-06-30Gallacher Capital Management LLC1.21413.786582488-2893-0.4942
2024-06-30Northern Trust Corp0.78860.0008378343-475-0.1254
2024-06-30Charles Schwab Investment Management Inc0.73240.00083513683497711.055
2024-03-31Morgan Stanley - Brokerage Accounts0.42610.0003204421-336852-62.2333
2024-06-30Nuveen Asset Management, LLC0.35270.000616921069994.3148
2024-06-30NORGES BANK0.30770.0003147639-68864-31.8074
2024-06-30Clear Creek Investment Mgmt LLC0.30340.217814555070255.0713
2024-06-30Bank of New York Mellon Corp0.29360.00031408472155818.0721
2024-06-30Bank of America Corp0.25140.0001120591-23314-16.201
2024-06-30Susquehanna Portfolio Strategies LLC0.21970.053610542600
2024-06-30Capital Fund Management SA0.20620.003698922989220
2024-06-30Goldman Sachs Group Inc0.17770.0002852453241461.3541
2024-03-31UBS Group AG0.17660.0004847268901.0616
2024-03-31Advisor Group Holdings, Inc.0.1720.003782534-35710-30.2003
2024-06-30Swiss National Bank0.16820.00078070021002.6718
Total 24.00354.07411515990+1061807+9.2%

4.9.2. Funds holding Cassava Sciences Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-07-31Vanguard Total Stock Mkt Idx Inv3.02380.0019145070000
2024-08-30iShares Russell 2000 ETF2.28640.0442109693869290.6357
2024-07-31Vanguard Institutional Extnd Mkt Idx Tr1.4590.014469998441670.5989
2024-06-30Fidelity Small Cap Index0.86630.0191415632141413.5221
2024-08-30YieldMax Ultra Option Income Strat ETF0.78165.543137500000
2024-08-30iShares Russell 2000 Growth ETF0.75020.0876359937-428-0.1188
2024-07-31State St Russell Sm/Mid Cp® Indx NL Cl C0.57580.013327626500
2024-07-31Fidelity Extended Market Index0.55840.0145267880114194.4525
2024-08-31Schwab US Small-Cap ETF™0.44450.034221326400
2024-08-30SPDR® S&P Pharmaceuticals ETF0.37992.796118223900
2024-07-31Vanguard Russell 2000 ETF0.33240.032615949282965.4869
2024-07-31State St Russell Sm Cap® Indx SL Cl I0.30560.031414662000
2024-07-31Vanguard Health Care ETF0.28830.0146138315-720-0.5179
2023-12-31NT R2000 Growth Index Fund - NL0.24850.0726119218-1136-0.9439
2024-08-30iShares US Pharmaceuticals ETF0.24670.482911836400
2024-07-31Schwab Small Cap Index0.20590.03379876425042.6013
2024-06-30BlackRock Extended Equity Market K0.20240.0087970961401016.862
2024-06-30NT R2000 Index Fund - NL0.19760.019294791-17928-15.905
2024-06-30Northern Trust Russell 2000 Growth Index0.17960.038886171-322-0.3723
2024-06-30NT R2000 Growth Index Fund - L0.17960.038686171-322-0.3723
Total 13.51259.34156482841+40610+0.6%

5.3. Insider Transactions

Insiders are holding 12.024% of the shares of Cassava Sciences Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-08-23Sanford RobertsonBUY4200012.46
2023-08-21Richard BarryBUY266812
2023-08-21Richard BarryBUY266812
2023-03-06Richard BarryBUY1619018.66
2022-08-23James William KupiecBUY350017.46
2022-08-23Richard BarryBUY5062216.99
2022-08-12Eric SchoenBUY350014.25
2022-08-12Sanford RobertsonBUY14000014.78
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets243,568
Total Liabilities54,594
Total Stockholder Equity188,974
 As reported
Total Liabilities 54,594
Total Stockholder Equity+ 188,974
Total Assets = 243,568

Assets

Total Assets243,568
Total Current Assets222,122
Long-term Assets21,446
Total Current Assets
Cash And Cash Equivalents 207,291
Net Receivables 1,439
Other Current Assets 13,392
Total Current Assets  (as reported)222,122
Total Current Assets  (calculated)222,122
+/-0
Long-term Assets
Property Plant Equipment 21,364
Intangible Assets 82
Long-term Assets Other 0
Long-term Assets  (as reported)21,446
Long-term Assets  (calculated)21,446
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities54,594
Long-term Liabilities0
Total Stockholder Equity188,974
Total Current Liabilities
Accounts payable 52,552
Other Current Liabilities 2,042
Total Current Liabilities  (as reported)54,594
Total Current Liabilities  (calculated)54,594
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock48
Retained Earnings -349,571
Other Stockholders Equity 538,497
Total Stockholder Equity (as reported)188,974
Total Stockholder Equity (calculated)188,974
+/-0
Other
Capital Stock48
Cash and Short Term Investments 207,291
Common Stock Shares Outstanding 46,202
Liabilities and Stockholders Equity 243,568
Net Debt -207,291
Net Invested Capital 188,974
Net Working Capital 167,528
Property Plant and Equipment Gross 24,143



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-31
> Total Assets 
22,865
21,139
82,841
81,147
81,147
74,504
71,470
68,136
64,032
60,640
56,691
53,325
48,028
44,531
86,638
80,513
72,425
62,904
55,802
101,192
92,772
83,190
73,774
215,795
215,778
213,243
218,286
208,456
212,245
208,633
208,810
207,625
192,497
179,122
195,497
193,436
189,733
186,316
182,732
182,005
178,597
182,084
180,794
99,195
101,226
102,593
100,592
98,963
96,810
94,440
93,259
56,859
54,870
53,200
51,756
50,103
47,319
45,391
43,591
40,906
39,635
37,756
35,653
31,918
28,626
24,940
22,482
19,302
17,604
14,269
12,377
10,831
11,058
9,833
20,836
20,139
19,523
18,805
18,375
23,486
25,977
25,498
25,399
94,300
284,050
281,305
274,249
266,782
244,191
227,381
207,286
234,834
218,111
197,248
172,529
151,663
155,718
243,568
243,568155,718151,663172,529197,248218,111234,834207,286227,381244,191266,782274,249281,305284,05094,30025,39925,49825,97723,48618,37518,80519,52320,13920,8369,83311,05810,83112,37714,26917,60419,30222,48224,94028,62631,91835,65337,75639,63540,90643,59145,39147,31950,10351,75653,20054,87056,85993,25994,44096,81098,963100,592102,593101,22699,195180,794182,084178,597182,005182,732186,316189,733193,436195,497179,122192,497207,625208,810208,633212,245208,456218,286213,243215,778215,79573,77483,19092,772101,19255,80262,90472,42580,51386,63844,53148,02853,32556,69160,64064,03268,13671,47074,50481,14781,14782,84121,13922,865
   > Total Current Assets 
22,283
20,073
82,576
79,773
79,773
71,964
68,963
65,714
61,693
58,389
54,530
51,247
46,036
42,625
84,816
78,750
70,540
61,038
53,974
99,656
91,293
81,685
72,087
214,164
214,147
211,693
216,859
207,114
210,254
206,659
206,407
205,374
190,363
177,105
193,598
190,636
187,605
184,255
180,981
178,471
177,714
181,260
180,028
98,484
100,557
101,964
100,084
98,489
96,371
94,037
92,907
56,507
54,518
52,848
51,416
50,103
47,243
45,307
43,510
40,829
39,367
37,502
35,413
31,691
28,413
24,741
22,220
19,070
17,390
14,079
12,204
10,663
10,889
9,699
20,720
20,040
19,265
18,583
18,189
23,349
25,877
25,440
25,071
93,994
283,766
279,558
251,915
244,482
222,200
204,201
183,272
211,226
194,999
174,533
150,184
129,633
133,999
222,122
222,122133,999129,633150,184174,533194,999211,226183,272204,201222,200244,482251,915279,558283,76693,99425,07125,44025,87723,34918,18918,58319,26520,04020,7209,69910,88910,66312,20414,07917,39019,07022,22024,74128,41331,69135,41337,50239,36740,82943,51045,30747,24350,10351,41652,84854,51856,50792,90794,03796,37198,489100,084101,964100,55798,484180,028181,260177,714178,471180,981184,255187,605190,636193,598177,105190,363205,374206,407206,659210,254207,114216,859211,693214,147214,16472,08781,68591,29399,65653,97461,03870,54078,75084,81642,62546,03651,24754,53058,38961,69365,71468,96371,96479,77379,77382,57620,07322,283
       Cash And Cash Equivalents 
22,179
20,021
81,997
78,927
78,927
71,642
68,442
65,274
61,359
57,806
53,893
50,091
45,664
42,546
46,900
12,027
7,181
3,172
1,750
1,379
107
2,512
1,421
95,651
67,825
51,109
31,558
16,386
61,816
49,191
40,814
86,567
130,807
125,425
143,950
153,158
172,790
145,200
29,169
35,794
50,657
66,773
106,292
4,798
54,894
62,830
71,709
73,144
73,779
79,020
88,240
56,254
51,591
51,545
51,027
49,838
47,102
44,825
42,052
40,590
39,248
36,352
33,993
31,299
26,614
24,626
21,764
18,714
17,264
14,067
11,916
10,479
10,734
9,608
20,444
19,807
19,125
18,534
17,804
23,081
25,600
25,254
24,074
93,506
282,192
278,254
241,524
233,437
209,693
197,232
174,662
201,015
187,467
168,438
142,350
121,136
124,169
207,291
207,291124,169121,136142,350168,438187,467201,015174,662197,232209,693233,437241,524278,254282,19293,50624,07425,25425,60023,08117,80418,53419,12519,80720,4449,60810,73410,47911,91614,06717,26418,71421,76424,62626,61431,29933,99336,35239,24840,59042,05244,82547,10249,83851,02751,54551,59156,25488,24079,02073,77973,14471,70962,83054,8944,798106,29266,77350,65735,79429,169145,200172,790153,158143,950125,425130,80786,56740,81449,19161,81616,38631,55851,10967,82595,6511,4212,5121071,3791,7503,1727,18112,02746,90042,54645,66450,09153,89357,80661,35965,27468,44271,64278,92778,92781,99720,02122,179
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
36,290
55
63,004
57,820
51,809
98,018
0
79,138
70,126
117,001
141,963
154,232
182,360
188,014
148,144
157,136
165,113
118,504
59,245
51,648
49,240
36,937
12,784
37,017
148,306
139,965
124,876
109,469
73,450
86,428
43,583
38,211
27,651
24,987
22,117
14,922
4,289
6,899
2,800
1,300
1,300
1,250
1,250
250
1,100
0
1,999
950
900
0
1,500
0
550
2,099
2,099
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000002,0992,09955001,50009009501,99901,1002501,2501,2501,3001,3002,8006,8994,28914,92222,11724,98727,65138,21143,58386,42873,450109,469124,876139,965148,30637,01712,78436,93749,24051,64859,245118,504165,113157,136148,144188,014182,360154,232141,963117,00170,12679,138098,01851,80957,82063,0045536,29000000000000000
       Net Receivables 
32
6
8
445
445
255
200
117
96
83
74
55
46
38
0
65,402
65,402
0
-415
98,018
91,034
0
0
889
4,234
6,305
2,596
0
0
0
0
0
0
0
0
0
0
0
0
2,302
0
0
0
7,114
1,996
908
231
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
86
0
1,271
0
0
0
0
0
0
0
0
1,328
1,285
962
1,000
1,439
1,4391,0009621,2851,328000000001,271086000000000000000000000000000000000002319081,9967,1140002,3020000000000002,5966,3054,2348890091,03498,018-415065,40265,40203846557483961172002554454458632
       Other Current Assets 
72
46
571
0
401
67
321
323
238
500
563
1,101
326
41
1,626
1,321
355
46
415
259
152
35
540
623
125
47
345
2,714
294
332
480
303
311
32
408
541
2,031
2,038
3,506
2,712
2,181
5,018
286
144
84
101,056
493
358
475
95
378
253
127
3
389
265
141
482
358
239
119
200
520
392
299
115
456
356
126
12
288
184
155
91
276
233
140
49
385
268
277
186
225
488
1,574
1,304
10,391
11,045
69
6,969
8,610
10,211
7,532
6,095
7,834
7,535
8,830
13,392
13,3928,8307,5357,8346,0957,53210,2118,6106,9696911,04510,3911,3041,574488225186277268385491402332769115518428812126356456115299392520200119239358482141265389312725337895475358493101,056841442865,0182,1812,7123,5062,0382,031541408323113034803322942,7143454712562354035152259415463551,3211,626413261,1015635002383233216740105714672
   > Long-term Assets 
582
1,066
265
0
1,374
2,540
2,506
2,421
2,339
2,251
2,161
2,078
1,992
1,906
1,822
1,763
1,885
1,866
1,828
1,536
1,479
1,505
1,687
1,631
1,631
1,550
1,427
1,342
1,991
1,974
2,403
2,251
2,134
2,017
1,899
2,800
2,128
2,061
1,751
3,534
883
824
766
711
669
629
508
474
439
403
352
352
352
352
340
7,504
76
84
81
77
268
254
240
227
213
199
262
232
214
190
173
168
169
134
116
99
258
222
186
137
100
58
330
306
284
1,747
22,334
22,300
21,991
23,180
24,014
23,608
23,112
22,715
22,345
22,030
21,719
21,446
21,44621,71922,03022,34522,71523,11223,60824,01423,18021,99122,30022,3341,7472843063305810013718622225899116134169168173190214232262199213227240254268778184767,5043403523523523524034394745086296697117668248833,5341,7512,0612,1282,8001,8992,0172,1342,2512,4031,9741,9911,3421,4271,5501,6311,6311,6871,5051,4791,5361,8281,8661,8851,7631,8221,9061,9922,0782,1612,2512,3392,4212,5062,5401,37402651,066582
       Property Plant Equipment 
122
124
265
1,299
1,299
2,465
2,431
2,346
2,264
2,176
2,086
2,003
1,917
1,831
1,747
1,688
1,810
1,791
1,753
1,461
1,404
1,430
1,612
1,556
1,556
1,475
1,352
1,267
1,223
1,206
1,549
1,607
1,490
1,373
1,256
774
708
641
578
517
457
398
340
285
232
192
157
122
87
52
352
0
0
0
0
0
76
72
69
100
256
242
228
200
201
187
250
300
214
190
173
200
139
122
104
100
246
210
174
137
100
58
330
306
284
327
20,926
20,826
21,051
22,321
23,274
22,986
22,609
22,328
22,077
21,854
21,604
21,364
21,36421,60421,85422,07722,32822,60922,98623,27422,32121,05120,82620,926327284306330581001371742102461001041221392001731902143002501872012002282422561006972760000035252871221571922322853403984575175786417087741,2561,3731,4901,6071,5491,2061,2231,2671,3521,4751,5561,5561,6121,4301,4041,4611,7531,7911,8101,6881,7471,8311,9172,0032,0862,1762,2642,3462,4312,4651,2991,299265124122
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,209
1,075
940
859
740
622
503
387
268
176
115
82
821151762683875036227408599401,0751,20900000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Long-term Assets Other 
460
942
0
75
75
75
75
75
75
75
75
75
75
75
75
75
75
75
75
75
75
75
75
75
75
75
75
75
768
768
854
644
644
644
643
2,026
1,420
1,420
1,173
3,017
426
426
426
426
437
437
351
352
352
351
352
352
352
352
340
7,504
0
12
12
-23
12
12
12
27
12
12
12
-68
232
0
0
-32
30
12
12
-1
12
12
12
90
67
45
0
295
274
1,420
199
399
188
166
144
0
0
0
0
0
0
0
00000001441661883991991,4202742950456790121212-1121230-3200232-6812121227121212-23121207,5043403523523523523513523523514374374264264264263,0171,1731,4201,4202,026643644644644854768768757575757575757575757575757575757575757575757575750942460
> Total Liabilities 
488
720
1,352
2,452
2,452
1,487
1,386
2,519
1,993
2,003
1,460
3,101
2,319
2,395
4,018
3,951
5,820
5,161
7,127
7,796
8,221
8,253
7,635
152,435
149,498
144,191
136,950
130,541
121,120
115,122
109,762
103,711
100,174
95,735
92,983
89,150
85,557
80,463
76,671
73,753
68,647
71,398
69,603
66,262
62,829
59,562
57,106
54,570
51,512
48,271
46,927
43,723
41,460
39,025
37,504
1,801
1,618
1,739
2,383
850
1,200
1,813
2,586
2,551
3,344
1,953
2,167
665
883
999
1,010
1,132
758
1,287
862
511
970
982
930
1,387
1,145
1,314
1,426
2,100
2,863
4,825
6,684
12,867
7,097
9,011
8,567
7,295
14,106
17,895
17,414
14,195
77,121
54,594
54,59477,12114,19517,41417,89514,1067,2958,5679,0117,09712,8676,6844,8252,8632,1001,4261,3141,1451,3879309829705118621,2877581,1321,0109998836652,1671,9533,3442,5512,5861,8131,2008502,3831,7391,6181,80137,50439,02541,46043,72346,92748,27151,51254,57057,10659,56262,82966,26269,60371,39868,64773,75376,67180,46385,55789,15092,98395,735100,174103,711109,762115,122121,120130,541136,950144,191149,498152,4357,6358,2538,2217,7967,1275,1615,8203,9514,0182,3952,3193,1011,4602,0031,9932,5191,3861,4872,4522,4521,352720488
   > Total Current Liabilities 
488
720
1,352
2,452
2,452
1,487
1,386
2,519
1,993
2,003
1,460
3,101
2,319
2,395
4,018
3,951
5,820
5,161
7,127
7,796
8,221
8,253
7,635
32,347
35,960
37,203
36,512
36,654
33,023
33,575
34,762
20,657
20,706
19,854
20,683
20,114
19,577
18,069
18,110
18,511
12,692
13,760
14,689
14,071
13,361
12,818
13,085
13,272
12,938
12,421
13,800
9,999
9,694
9,218
9,655
1,801
1,618
1,739
2,383
850
1,200
1,813
2,586
2,551
3,344
1,953
2,167
665
883
999
1,010
1,132
758
1,287
862
511
902
937
907
1,387
1,145
1,314
1,168
1,865
2,650
4,637
6,326
12,534
6,789
8,722
8,308
7,063
13,909
17,895
17,414
14,195
77,121
54,594
54,59477,12114,19517,41417,89513,9097,0638,3088,7226,78912,5346,3264,6372,6501,8651,1681,3141,1451,3879079379025118621,2877581,1321,0109998836652,1671,9533,3442,5512,5861,8131,2008502,3831,7391,6181,8019,6559,2189,6949,99913,80012,42112,93813,27213,08512,81813,36114,07114,68913,76012,69218,51118,11018,06919,57720,11420,68319,85420,70620,65734,76233,57533,02336,65436,51237,20335,96032,3477,6358,2538,2217,7967,1275,1615,8203,9514,0182,3952,3193,1011,4602,0031,9932,5191,3861,4872,4522,4521,352720488
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,295
6,690
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,820
0
0
576
0
0
0
0
793
929
0
0
742
41,760
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
90
90
90
90
67
45
58
58
84
93
95
97
99
100
102
104
0
0
0
0
0
0
000000104102100999795938458584567909090900000000000000000000041,760742009297930000576007,820000000000000006,6906,29500000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
90
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000900000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
488
720
1,352
0
2,313
1,343
1,231
2,170
1,446
1,406
1,072
2,648
1,728
1,731
3,537
3,441
5,105
817
831
877
904
1,006
564
998
820
596
438
985
840
2,220
3,008
3,624
2,962
3,206
3,485
2,216
1,685
975
1,005
1,317
485
625
715
1,107
436
604
556
464
502
501
507
1,290
366
435
1,273
1,086
729
692
822
198
462
465
898
1,928
1,043
1,019
1,827
330
573
658
712
424
421
962
549
294
495
594
340
453
608
416
465
911
864
1,912
2,345
7,126
3,332
4,758
3,534
4,017
8,242
10,338
9,492
10,573
9,603
52,552
52,5529,60310,5739,49210,3388,2424,0173,5344,7583,3327,1262,3451,9128649114654166084533405944952945499624214247126585733301,8271,0191,0431,9288984654621988226927291,0861,2734353661,2905075015024645566044361,1077156254851,3171,0059751,6852,2163,4853,2062,9623,6243,0082,2208409854385968209985641,0069048778318175,1053,4413,5371,7311,7282,6481,0721,4061,4462,1701,2311,3432,31301,352720488
       Other Current Liabilities 
0
0
0
0
139
144
155
349
547
597
388
453
591
664
481
510
715
4,344
6,296
6,919
7,317
7,247
7,071
5,149
8,940
10,407
3,579
2,779
5,983
5,155
5,554
2,685
3,396
2,300
2,850
3,550
3,544
2,746
2,757
2,846
2,110
2,238
10,897
2,067
2,028
741
1,632
1,911
1,539
1,023
1,603
1,806
1,496
951
1,292
1,356
889
1,047
1,561
652
738
1,348
1,688
623
2,301
934
340
335
310
341
298
708
337
325
313
217
12
14
7
9
11
14
7
94
50
50
509
631
3,358
3,864
4,672
2,942
5,667
7,557
7,922
3,622
67,518
2,042
2,04267,5183,6227,9227,5575,6672,9424,6723,8643,358631509505094714119714122173133253377082983413103353409342,3016231,6881,3487386521,5611,0478891,3561,2929511,4961,8061,6031,0231,5391,9111,6327412,0282,06710,8972,2382,1102,8462,7572,7463,5443,5502,8502,3003,3962,6855,5545,1555,9832,7793,57910,4078,9405,1497,0717,2477,3176,9196,2964,3447155104816645914533885975473491551441390000
   > Long-term Liabilities 
488
720
1,352
0
2,313
1,343
1,231
2,170
1,446
1,406
1,072
2,648
1,728
1,731
3,537
3,441
5,105
817
831
877
904
1,006
564
120,088
113,538
106,988
100,438
93,887
88,097
81,547
75,000
83,054
79,468
75,881
72,300
69,036
65,980
62,394
58,561
55,242
55,955
57,638
54,914
52,191
49,468
46,744
44,021
41,298
38,574
35,850
33,127
33,724
31,766
29,807
27,849
445
428
360
822
173
255
465
898
1,034
1,043
378
1,083
303
573
658
712
424
421
962
549
294
68
45
23
543
675
461
258
235
213
188
358
333
308
289
259
232
197
0
0
0
0
0
000001972322592893083333581882132352584616755432345682945499624214247126585733031,0833781,0431,03489846525517382236042844527,84929,80731,76633,72433,12735,85038,57441,29844,02146,74449,46852,19154,91457,63855,95555,24258,56162,39465,98069,03672,30075,88179,46883,05475,00081,54788,09793,887100,438106,988113,538120,0885641,0069048778318175,1053,4413,5371,7311,7282,6481,0721,4061,4462,1701,2311,3432,31301,352720488
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
194
194
194
201
197
197
0
0
0
0
0
0
00000019719720119419419400000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
46,312
43,587
41,298
38,574
35,850
33,127
33,724
31,766
29,807
27,849
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000000000027,84929,80731,76633,72433,12735,85038,57441,29843,58746,312000000000000000000000000000000000000000000000
> Total Stockholder Equity
22,377
20,418
81,489
0
78,695
73,017
70,084
65,616
62,038
58,636
55,231
50,224
45,709
42,136
82,620
76,562
66,605
57,743
48,675
93,396
84,551
74,937
66,139
63,360
66,280
69,052
81,336
77,915
91,125
93,511
99,048
103,914
92,323
83,387
102,514
104,286
104,176
105,853
106,061
108,252
109,950
110,686
111,191
32,933
38,397
43,031
43,486
44,393
45,298
46,169
46,332
13,136
13,410
14,175
14,252
48,302
45,701
43,652
41,208
40,056
38,435
35,943
33,067
29,367
25,282
22,987
20,315
18,637
16,721
13,270
11,367
9,699
10,300
8,546
19,974
19,628
18,553
17,823
17,445
22,099
24,832
24,184
23,973
92,200
281,187
276,480
267,565
253,915
237,094
218,370
198,719
227,539
204,005
179,353
155,115
137,468
78,597
188,974
188,97478,597137,468155,115179,353204,005227,539198,719218,370237,094253,915267,565276,480281,18792,20023,97324,18424,83222,09917,44517,82318,55319,62819,9748,54610,3009,69911,36713,27016,72118,63720,31522,98725,28229,36733,06735,94338,43540,05641,20843,65245,70148,30214,25214,17513,41013,13646,33246,16945,29844,39343,48643,03138,39732,933111,191110,686109,950108,252106,061105,853104,176104,286102,51483,38792,323103,91499,04893,51191,12577,91581,33669,05266,28063,36066,13974,93784,55193,39648,67557,74366,60576,56282,62042,13645,70950,22455,23158,63662,03865,61670,08473,01778,695081,48920,41822,377
   Common Stock
10
10
27
0
27
27
27
27
27
27
27
27
27
27
35
35
35
36
36
44
44
44
44
44
44
44
44
44
44
44
44
44
42
41
42
42
42
42
42
42
43
43
43
43
44
45
45
45
45
45
45
45
45
45
151,373
45
153,257
154,454
45
46
157,510
46
46
46
46
162,435
163,280
46
46
7
7
7
7
7
17
17
183,868
17
17
190,686
25
25
26
267,121
459,634
460,052
460,699
461,221
40
462,531
463,137
511,091
511,828
513,552
514,965
42
43
48
484342514,965513,552511,828511,091463,137462,53140461,221460,699460,052459,634267,121262525190,6861717183,8681717777774646163,280162,43546464646157,5104645154,454153,25745151,37345454545454545454544434343434242424242424142444444444444444444444444443636353535272727272727272727270271010
   Retained Earnings Total Equity0000-334,199-307,8230-264,418-244,161-224,833-207,306-193,134-183,572-178,447-174,9210-170,873-169,737-168,587-167,071-166,374-165,315-163,956-163,279-162,012-159,559-157,399-154,982-152,391-148,231-145,488-142,966-139,448-136,433-130,638-126,121-122,450-119,076-116,493-114,337-110,802-107,557-104,107-137,122-136,360-136,059-135,651-133,857-132,306-132,175-132,205-131,814-130,999000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
-8,572
-7,099
-6,914
-49
-5,146
-2,893
-2,406
-1,914
-1,480
-1,279
-1,388
-426
-318
-68
-1
43
157
-267
-122
-544
-823
-472
-512
-479
-815
-1,130
-291
-372
103
-177
354
584
905
465
-183
325
195
99
-31
347
664
473
693
525
468
394
121
128
96
43
2
4
1
1
1
1
1
0
1
1
1
1
1
-700
0
0
1
-700
-700
0
0
-800
0
0
0
-900
-900
0
0
-900
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000-90000-900-900000-80000-700-700100-70011111011111424396128121394468525693473664347-3199195325-183465905584354-177103-372-291-1,130-815-479-512-472-823-544-122-26715743-1-68-318-426-1,388-1,279-1,480-1,914-2,406-2,893-5,146-49-6,914-7,099-8,572
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
173,591
175,134
176,425
177,332
178,387
180,142
148,738
149,423
150,489
151,328
152,363
153,212
154,409
155,499
156,502
157,464
158,346
159,141
159,959
161,669
162,389
163,234
164,079
164,906
165,654
166,342
167,091
169,852
170,551
183,236
183,567
183,851
184,180
184,499
190,664
194,544
195,032
0
267,086
459,594
460,012
460,659
461,181
461,887
462,491
463,097
0
511,786
513,510
0
0
0
0
0000513,510511,7860463,097462,491461,887461,181460,659460,012459,594267,0860195,032194,544190,664184,499184,180183,851183,567183,236170,551169,852167,091166,342165,654164,906164,079163,234162,389161,669159,959159,141158,346157,464156,502155,499154,409153,212152,363151,328150,489149,423148,738180,142178,387177,332176,425175,134173,591000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
17,698
17,780
100,982
0
101,085
100,684
101,121
102,557
103,005
103,317
102,962
103,254
103,248
103,770
150,149
150,732
150,824
151,452
151,469
205,920
205,943
206,160
206,168
206,489
208,868
210,458
212,378
214,749
215,595
216,077
217,910
220,999
214,143
210,785
215,369
218,021
219,865
221,672
223,322
225,432
227,496
229,563
230,569
161,482
167,684
173,591
175,134
176,425
177,332
178,387
180,142
148,738
149,423
150,489
151,328
152,363
153,212
154,409
155,499
156,502
157,464
158,346
159,141
160,659
161,669
162,389
163,234
164,779
164,906
165,654
166,342
167,891
169,852
170,551
183,236
184,467
183,851
184,180
184,499
900
194,544
195,032
196,250
267,086
459,594
460,012
460,659
461,181
461,887
462,491
463,097
511,049
0
-953
514,923
518,195
434,280
538,497
538,497434,280518,195514,923-9530511,049463,097462,491461,887461,181460,659460,012459,594267,086196,250195,032194,544900184,499184,180183,851184,467183,236170,551169,852167,891166,342165,654164,906164,779163,234162,389161,669160,659159,141158,346157,464156,502155,499154,409153,212152,363151,328150,489149,423148,738180,142178,387177,332176,425175,134173,591167,684161,482230,569229,563227,496225,432223,322221,672219,865218,021215,369210,785214,143220,999217,910216,077215,595214,749212,378210,458208,868206,489206,168206,160205,943205,920151,469151,452150,824150,732150,149103,770103,248103,254102,962103,317103,005102,557101,121100,684101,0850100,98217,78017,698



5.3. Balance Sheets

Currency in USD. All numbers in thousands.